Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:01:18 2024-05-16 pm EDT Pre-market 07:13:59 am
28.92 USD +0.35% Intraday chart for Pfizer, Inc. 29.02 +0.36%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
GSK sells remaining Haleon stake for GBP1.25 billion AN
GSK raises $1.5 bln from sale of remaining Haleon stake RE
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update DJ
Global markets live: Cisco, EasyJet, Roche, Netflix, Amazon... Our Logo
Sector Update: Health Care Stocks Steady Premarket Thursday MT
Sector Update: Health Care MT
Correction: Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity MT
Arvinas, Pfizer Breast Cancer Treatment Shows 'Encouraging' Clinical Activity MT
Pfizer Offers to Settle Zantac Claims for Up to $250 Million MT
Basilea Pharmaceutica Receives Milestone Payment from Pfizer for Cresemba Sales MT
Pfizer offers up to $250 million to settle thousands of Zantac cancer lawsuits, FT reports RE
Global markets live: Pfizer, Chevron, Amazon, Booking, Apple, Novavax, SoftBank... Our Logo
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- 2nd Update DJ
France Secures $16 Billion From Microsoft, Amazon and Others at Foreign Investment Summit -- Update DJ
Pfizer, AstraZeneca, Morgan Stanley Pledge Investments, Jobs to France MT
Redburn Atlantic Adjusts Price Target on Pfizer to $27 From $26, Keeps Neutral Rating MT
France Secures Billions at Foreign Investment Summit DJ
Pfizer to Invest EUR500 Million for Research, Development in France MT
France gets $16 billion of foreign investments as part of 'Choose France' event RE
Pfizer and AstraZeneca announce new investments of nearly $1 billion in France RE
Pfizer announces 500 million euros investment in France RE
Novavax Surges on $1.2 Billion Sanofi Vaccine Deal MT
HLS Therapeutics Meets Q1 Earnings Forecast, But Misses on Revs; Lowers 2024 Vascepa Guidance MT
Sector Update: Health Care Stocks Softer Late Afternoon MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
Chart Pfizer, Inc.
More charts
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.92 USD
Average target price
31.94 USD
Spread / Average Target
+10.44%
Consensus
  1. Stock Market
  2. Equities
  3. PFE Stock
  4. News Pfizer, Inc.
  5. Leerink Adjusts Price Target on Pfizer to $29 From $27
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW